RFID: Why RFID Isn't the Next Big Thing

Why RFID isn’t the next big thing
By Tom Yager, San Francisco | Monday, 28 November, 2005

We’ll soon live in a world where sensors outnumber people. If you believe what you read, RFID is a magical technology that will forever banish wires, grocery store scanners, credit cards and pocket change from our working and personal lives. There will be no more theft, no more injuries from improper medication, no more lost remote controls and no more stray dogs.

While Sun Microsystems and others get us all worked up about sensors, equating them with RFID, those who actually work on and do research into embedded technology are having a laugh at consumers’ expense. Sensors, indeed. Passive RFID, the most common type because it’s the least expensive, costs about US7¢ (NZ10¢) per tag. But that doesn’t include back-end costs and expensive readers. People who design systems for factory floor automation, logistics tracking, warehouses, external and implantable medical devices and other blue collar and white-coat locales understand that RFID has limited, albeit important, applications.

I have a lot of reasons for being no fan of RFID but RFID has one serious, show-stopping shortcoming that trumps the others: it’s stupid. A passive RFID tag is incapable of learning, logging, or sensing the world around it, or doing anything on its own. If the tag is separated from the reader, or the reader is separated from the back end, the system is going to miss something. Active RFID, which can incorporate sensor-like capabilities, requires a battery or other source of power. When you cross that line, you’re not in RFID-land anymore. You’re just sending and receiving wireless data, the cost rises and smarter solutions are within reach.

To illustrate, consider the oft-cited use of RFID for hospital patients, to ensure that they get the proper medication and that they don’t get a kidney removed when they’re wheeled into the operating theatre for a blown-out knee. Knowing whom you’re dealing with is dandy but there’s a lot more a doctor would like to know about a patient, such as heart rate, respiration, temperature, blood oxygen, mobility and how much noise visitors are making. All of this data can be gathered and recorded by one micro-controller or custom-programmable logic device. I’ve found specific technical notes from semiconductor vendors for each of these applications. I also like the idea of encrypted and authenticated delivery.

In modern commercial packaging, the core of this type of smart monitor, and the lithium battery that drives it (for as long as five years), should be weightless and I’d estimate the per-patient cost to be about US$4 (NZ$5.80) using off-the-shelf parts.

A basic programmable ID bracelet could morph into an adhesive patch that’s placed on the chest to monitor heart rate, respiration and chest sounds. A programmable sensor integrated into a chest tube could alert medical staff when it’s leaking. However, nobody dreams of taking RFID that far.

If a technology doesn’t inspire big dreams, why invest in it? Dumping dough in RFID only takes money away from the R&D to create more capable, intelligent solutions.

Yager is chief technologist at the InfoWorld Test Centre.
Email him at tom_yager@infoworld.com
Published at http://computerworld.co.nz

Sally Bacchetta - Freelance Writer
Freelance Writer
RFID

RFID: FDA Update

A few weeks ago FDA Associate Commissioner Randall Lutter, Ph.D spoke at the first NACDS/HDMA* Summit on the adoption of RFID technology in healthcare.

His comments included an update on the FDA initiative to implement electronic pedigrees for tracking the manufacture and sale of prescription drugs, which until now has been a voluntary initiative.

Lutter stated, "Supply chain stakeholders assured us that there would be considerable movement toward implementation of RFID and that widespread adoption could be done in 2007... Yet from our vantage point today, it appears a voluntary approach may not be enough... We are concerned that widespread adoption may not be realized by December 2006, when the PDMA stay expires."

He announced that the FDA Counterfeit Drug Task Force will hold a Public Workshop in January or February 2006 to discuss barriers to implementation and to assert the FDA's commitment to adoption of electronic pedigree technology.

Lutter said "In the coming weeks, we will put out an invitation for people to testify on these and other issues and we expect to publish more information about this meeting in the near future both in the Federal Register and posted on FDA’s website."

Stay tuned.

*NACDS - National Association of Chain Drug Stores
HDMA - Health Department Management Association

Sally Bacchetta - Freelance Writer
Freelance Writer
RFID